Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Pharmacovigilance01:19

Pharmacovigilance

830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Ethical Standards II01:23

Ethical Standards II

662
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
662
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

125
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
125

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.

Journal of neuro-oncology·2025
Same author

Global Mpox efforts should consider substance use disorders and need to end stigma for those with mental health conditions.

The International journal of social psychiatry·2024
Same author

Audio-Only Telehealth for Behavioral Health Services May Support Health Equity.

The journal of behavioral health services & research·2024
Same author

Amidst spreading infectious diseases and climate change, US FDA should renew its focus on neglected tropical diseases.

PLoS neglected tropical diseases·2024
Same author

Manufactured scarcity and the allocation of scarce resources.

Lancet (London, England)·2024
Same author

Review of extreme heat and mental health will be useful for extreme heat preparedness efforts.

Psychiatry research·2024

Related Experiment Video

Updated: Jun 28, 2025

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
07:00

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

Published on: August 11, 2017

8.2K

Additional Steps for Maintaining Public Trust in the FDA.

Mitchell Berger

    The Hastings Center Report
    |April 19, 2024
    PubMed
    Summary

    This letter discusses rebuilding public trust in the Food and Drug Administration (FDA) and vaccine safety. It addresses challenges and proposes strategies for enhancing the FDA's trustworthiness in vaccine regulation.

    Area of Science:

    • Public Health Policy
    • Regulatory Science
    • Vaccine Trust

    Background:

    • Public trust in health institutions, particularly the Food and Drug Administration (FDA), is crucial for effective public health initiatives.
    • Recent discourse has highlighted concerns regarding the trustworthiness of regulatory bodies, impacting vaccine acceptance and uptake.
    • The essay 'Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines' provides a critical examination of these issues.

    Discussion:

    • The discussion centers on the critical need to bolster public confidence in regulatory bodies like the FDA.
    • It examines the multifaceted challenges in maintaining and rebuilding trust, particularly in the context of vaccine approval and public health communication.
    • Strategies for enhancing FDA trustworthiness are explored, considering the impact on public perception and vaccine acceptance.
    Keywords:
    FDAFreedom of Information Actbioethicsrevolving doortrustworthiness

    More Related Videos

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
    09:30

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    3.4K
    Working with Human Tissues for Translational Cancer Research
    07:48

    Working with Human Tissues for Translational Cancer Research

    Published on: November 26, 2015

    9.9K

    Related Experiment Videos

    Last Updated: Jun 28, 2025

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
    07:00

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

    Published on: August 11, 2017

    8.2K
    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
    09:30

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    3.4K
    Working with Human Tissues for Translational Cancer Research
    07:48

    Working with Human Tissues for Translational Cancer Research

    Published on: November 26, 2015

    9.9K

    Key Insights:

    • Rebuilding public trust in the FDA requires transparent and robust scientific processes.
    • Effective communication strategies are essential to convey the safety and efficacy of vaccines.
    • Addressing public concerns and misinformation is paramount for sustained confidence in public health institutions.

    Outlook:

    • Future efforts should focus on strengthening regulatory frameworks and public engagement to ensure vaccine confidence.
    • Continued dialogue and research are necessary to adapt to evolving public health challenges.
    • The long-term goal is to foster a resilient public trust in the FDA and vaccination programs.